Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.
about
Risk prediction models for contrast induced nephropathy: systematic reviewNephrogenic systemic fibrosis: a concise review for cardiologists.Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.Analysis of the sensitivity and specificity of noninvasive imaging tests for the diagnosis of renal artery stenosisFunctional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence.Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomographyIntraarterial CT Angiography Using Ultra Low Volume of Iodine Contrast - Own Experiences.Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease.Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.The Swedish CArdioPulmonary BioImage Study: objectives and designContrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease: A Nationwide Population-Based, Propensity Score-Matched, Longitudinal Follow-Up StudyContrast safety in the cancer patient: preventing contrast-induced nephropathy.Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods.Perfusion CT: is it clinically useful?CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy.Computed Tomography Angiography of the Head Is a Reasonable Next Test After a Negative Noncontrast Head Computed Tomography Result in the Emergency Department Evaluation of Subarachnoid Hemorrhage.Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.Imaging patients with renal impairment.Anatomo-radiological correlation using 18-FDG-PET in abdominal sepsis model in rats. A preliminary study.Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.Contrast media: are there differences in nephrotoxicity among contrast media?Contrast-induced acute kidney injury: definition, epidemiology, and outcomeContrast-induced nephropathy: pharmacology, pathophysiology and prevention.The effect of coronary angiography on renal function in preemptive renal transplant candidates.No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.Selecting a strategy for prevention of contrast-induced nephropathy in clinical practice: an evaluation of different clinical practice guidelines using the AGREE tool.Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study.Changing Paradigms in Contrast Nephropathy.Does the Current Definition of Contrast-induced Acute Kidney Injury Reflect a True Clinical Entity?
P2860
Q26796473-20796BA6-34CF-4B81-927E-3B963797816FQ28972564-15502600-5924-482C-97C9-DE34DAA5CA24Q33571334-A0E116C0-1662-4C57-B5A2-183E2C273987Q33843429-8B0680B4-0EEB-41A9-B247-216553FF0707Q33862673-7AF3E59B-7DE3-4347-9BC6-A8E5393656E9Q34372648-D2A98208-F728-4A9E-BD8C-FF50B2DA78F0Q35177924-E6AE3E4C-38FC-4D8D-B633-DAC3E2D56A28Q35230061-5E8F917D-0412-493D-B2E8-6420E5BB8AF9Q35626471-D7632EB3-3079-49E5-8374-08F2C1901E00Q35835371-BAC41883-2978-47E4-AAC5-8D284B7C4352Q35882934-DED1B53C-2E2F-4AD3-926E-0C693299ABC3Q35994239-44AD3B21-3F8D-443C-9F06-0007B6325F0FQ36513004-6F527A4A-92C1-4AFA-9552-F83E2F4C4EB0Q36555278-147866C2-7177-4F5A-B935-AC871FF690DDQ36710941-6CB08D22-ADEA-4269-B679-288AF5C4C73BQ36755878-AE536415-F8BE-41D8-A8CA-F07A2F36D633Q36838026-0BF2DAD8-FE6C-4D79-9CA3-6141ABBEA85DQ36971717-937ACA5D-7468-4D8A-BA7F-8105A61FAEB9Q37149577-4C0AC9B6-30A8-409A-9A09-5E0AA86AB019Q37193034-CD093F9C-BFB0-40CD-B6FB-6E303CC53B14Q37244433-32E61885-8535-4CAB-9583-D6B4834D8DF1Q37304873-D1489D45-9417-42F7-90A7-EE8DE3DC2EABQ37682442-526F0A38-1BCC-4603-9220-72FA006C492FQ37981625-9A041F15-8D1E-46E3-9E34-A5DE94397293Q38006819-DA466A8E-F5B8-4AE4-99AE-41B7E811E070Q38199743-3DFC8252-7A6C-4979-9566-7C8B91CA77EEQ38789239-7B82F16A-5761-47C5-A76A-1FC8F7D29318Q38840116-A9671FCF-0443-4B09-8D08-12401A8877BBQ38885896-38CE615B-DEBD-4332-B8E8-6C0657AA141DQ39120881-60A1C161-8AD1-4C46-B4EA-BB68B874FE03Q41821811-E86F49BB-D180-465A-B0E2-E0E79717A88FQ42394147-304730C7-3314-4D87-87F7-CF7535827FC6Q42854993-EF43EBFD-2DE2-4368-890E-96A917FE2F3EQ45024596-FBC54097-C177-489D-8813-76551D2AD87EQ46558729-34819637-A69C-44C0-80A8-00FA5C330E27Q49134110-98949740-740C-4B06-88D4-1D53BE6EB517Q50090707-33A1EA81-9B3C-4F53-84A8-C3505C275DB9Q52951542-ABC7E887-E8CB-4F6C-8719-2A7AAB45AB2DQ55001414-353CAE8B-2AEC-42E8-A029-66668D78FF56Q58386419-90BC84BB-F1CF-4A38-AE66-E2960763F30B
P2860
Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Risk of nephropathy after intr ...... critical literature analysis.
@ast
Risk of nephropathy after intr ...... critical literature analysis.
@en
type
label
Risk of nephropathy after intr ...... critical literature analysis.
@ast
Risk of nephropathy after intr ...... critical literature analysis.
@en
prefLabel
Risk of nephropathy after intr ...... critical literature analysis.
@ast
Risk of nephropathy after intr ...... critical literature analysis.
@en
P1433
P1476
Risk of nephropathy after intr ...... critical literature analysis.
@en
P2093
Jeffrey H Newhouse
Qasim Ali Rao
P304
P356
10.1148/RADIOL.2392050413
P407
P577
2006-03-16T00:00:00Z